7/3/2007

A U.S. team found a cellular receptor known as "RON receptor tyrosine kinase" is overexpressed in pancreatic cancer cells. Scientists said that combining antibodies that block the receptor may be more effective in killing cancer cells than standard treatment.

Full Story:
Forbes

Related Summaries